Vitamin D insufficiency, defined as low serum concentrations of the major circulating form of vitamin D, 25 hydroxyvitamin D (25(OH)D), has been associated with the development of numerous infectious, inflammatory, and neoplastic disorders in humans. In addition, vitamin D insufficiency has been found to be predictive of mortality for many disorders. However, interpretation of human studies is difficult since vitamin D status is influenced by many factors, including diet, season, latitude, and exposure to UV radiation. In contrast, domesticated cats do not produce vitamin D cutaneously, and most cats are fed a commercial diet containing a relatively standard amount of vitamin D. Consequently, domesticated cats are an attractive model system in which to examine the relationship between serum 25(OH)D and health outcomes. The hypothesis of this study was that vitamin D status would predict short term, all-cause mortality in domesticated cats. Serum concentrations of 25(OH)D, together with a wide range of other clinical, hematological, and biochemical parameters, were measured in 99 consecutively hospitalised cats. Cats which died within 30 days of initial assessment had significantly lower serum 25(OH)D concentrations than cats which survived. In a linear regression model including 12 clinical variables, serum 25(OH)D concentration in the lower tertile was significantly predictive of mortality. The odds ratio of mortality within 30 days was 8.27 (95% confidence interval 2.54-31.52) for cats with a serum 25(OH)D concentration in the lower tertile. In conclusion, this study demonstrates that low serum 25(OH)D concentration status is an independent predictor of short term mortality in cats.
Citation: Titmarsh H, Kilpatrick S, Sinclair J, Boag A, Bode EF, Lalor SM, et al. (2015) Vitamin D Status Predicts 30 Day Mortality in Hospitalised Cats. PLoS ONE 10(5): e0125997. https://doi.org/10.1371/journal.pone.0125997
Academic Editor: Andrzej T. Slominski, University of Alabama at Birmingham, UNITED STATES
Received: February 1, 2015; Accepted: March 27, 2015; Published: May 13, 2015
Copyright: © 2015 Titmarsh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper.
Funding: The study was supported by a grant from the Pet Plan Charitable Trust (grant number Petplan 12-39, received by RM) (http://www.petplantrust.org/).
Competing interests: The authors have declared that no competing interests exist.
Vitamin D is traditionally known for its role in calcium homeostasis and bone metabolism. However, it has been demonstrated that numerous types of cells express the vitamin D receptor and it is now clear that the physiological roles of vitamin D extend beyond the maintenance of skeletal health [1, 2]. Vitamin D insufficiency, which is typically assessed by measuring the major circulating form of vitamin D, 25 hydroxyvitamin D (25(OH)D), has been associated with a number of disorders including hypertension , diabetes , cardiovascular diseases , cancer , autoimmune conditions  and infectious diseases [8–10]. Furthermore, low serum 25(OH)D concentrations have also been linked to all-cause mortality in the general human population . Meta-analyses have demonstrated that serum 25(OH) concentrations are an important predictor of survival in people with a wide variety of illnesses [12–15].
However, interpretation of these studies is challenging. A large number of factors are known to influence serum 25(OH)D concentrations in humans including ethnicity [16–18], diet [18–20], seasonality , latitude and exposure to sunlight [22–24], obesity[25, 26], age  and gender . Consequently, exploring the relationship between serum 25(OH)D concentrations and all-cause mortality in a model system in which many of these confounding factors are avoided would be of significant interest. Furthermore, a model system which did not require disease to be induced in otherwise healthy animals would allow the number of animals used in scientific research to be reduced. We predict that client owned, domesticated cats which developed spontaneous disease would be a suitable model in which to study the relationship between vitamin D and all-cause mortality. Advantages of investigating the role of 25(OH)D on health outcomes in cats include a more standard dietary intake of vitamin D since almost all cats which attend our referral veterinary hospital eat a commercial diet which is supplemented with a similar amount of vitamin D . In addition, cats do not synthesize vitamin D cutaneously meaning that serum 25(OH)D concentrations are not influenced by exposure to UV radiation [30, 31].
Investigating the role of serum 25(OH)D concentrations and all-cause mortality in cats would be of interest to veterinarians since it is presently difficult to accurately predict mortality in hospitalised, ill cats. The identification of clinical measures which were predictive of mortality would be extremely helpful in providing much needed prognostic information to owners of ill cats. The aim of this study was to investigate whether serum 25(OH)D concentrations was a predictor of short term, all-cause mortality in hospitalised ill cats. We have recently demonstrated that vitamin D metabolism is altered in dogs and cats with a wide range of infectious, inflammatory and neoplastic conditions, highlighting the need to clarify the relationship between serum 25(OH)D concentrations and mortality [32–38]. We hypothesised that cats with low serum 25(OH)D concentrations would have higher mortality at 30 days post admission than cats which were vitamin D replete.
Material and Methods
Consecutive cats examined at the Royal (Dick) School of Veterinary Studies, Hospital for Small Animals were considered eligible for inclusion in the study. Informed consent for the use of residual clinical blood samples for research purposes was obtained at admission for each cat enrolled. Ethical approval for the study was obtained from the University of Edinburgh’s Veterinary Ethical Review Committee.
Clinical records were reviewed for each cat enrolled. The age, sex and breed were recorded for each cat. Survival data was obtained from clinical records or follow up telephone calls to clients and referral veterinary surgeons for each cat at day 30 post initial presentation. The following clinical information was extracted for each patient: white blood cell count, packed cell volume (PCV), serum albumin, serum creatinine, sodium concentrations, potassium concentrations, total calcium concentration and 25(OH)D concentrations. In addition, the appetite of the cats was graded as normal or reduced. Haematology variables were measured on an ADVIA(r) 2120i System with Autoslide (Siemens Medical Solutions Diagnostics Ltd California, USA). Biochemistry parameters (serum sodium, potassium, creatinine, albumin and total calcium) concentrations were measured on an ILab650 biochemistry analyser, (Diamond Diagnostics, USA).
Following handling of blood samples for routine diagnostic procedures, serum samples were stored initially at -20°C and later moved to -70°C for longer term storage until 25(OH)D concentrations were measured as a batch. Previous studies have indicated that 25(OH)D is stable when stored at -20°C . Serum concentrations of 25(OH)D2 and 25(OH)D3 were determined by liquid chromatography tandem mass spectrophotometry (LC-MS/MS) using an ABSciex 5500 tandem mass spectrophotometer (Warrington, UK) and the Chromsystems (Munich, Germany) 25OHD kit for LC-MS/MS following the manufacturers’ instructions (intra- and inter-assay CV 3.7% and 4.8% respectively). This Supraregional Assay Service laboratory is accredited by CPA UK (CPA number 0865) and has been certified as proficient by the international Vitamin D Quality Assurance Scheme (DEQAS). Total 25(OH)D is defined as the sum of 25(OH)D2 and 25(OH)D3. The laboratory measuring the vitamin D metabolites were blinded to clinical data from the enrolled cats. In addition, clinicians were not aware of 25(OH)D results during the clinical management of the cats.
Initially, we compared the 25(OH)D concentrations between cats which died within 30 days of sampling to cats which survived by a Mann-Whitney U test. In order to investigate for the presence of confounding variables we constructed a standard binary logistic regression model of death by 30 days. We included a range of clinical and biochemical data including sex, age, breed, total white blood cells, packed cell volume and serum concentrations of albumin, total calcium, creatinine, sodium and potassium. We also included an assessment of appetite as a binary variable of normal or reduced. Initially we included 25(OH)D concentrations as a linear predictor within the logistical regression model. We also categorised serum 25(OH)D concentration into 3 categories based on 33% and 66% tertiles treating the variable as a three level factor and also as low versus middle and high categories combined. We used Akaike’s information criteria (AIC—a parameter penalised measure of model fit) to stepwise select variables which were to be retained to identify a final model with minimum AIC (i.e. best parameter penalised fit). P values for individual variables were calculated using Wald’s test. A p-value of < 0.05 was considered to be evidence of statistical significance.
A total of 99 cats were recruited to the study. The median age of the cats was 96 months. There were 3 entire male, 56 neutered males, 1 entire female and 39 neutered female cats. Breeds included in the study were 62 Domestic Short Hairs, 8 Domestic Long Hairs, 6 Maine Coons, 5 Burmese, 3 Bengals, 2 Tomikense, 2 Siamese, 2 Ragdolls, 2 Burmese crosses, 2 Oriental Short Hair, 1 Manx Cat, 1 British Short Hair, 1 Chinchilla, 1 Burmillia and 1 Abyssinian.
There was a significant difference between the 25(OH) D concentrations between cats which were alive (n = 80) compared to cats which had died at 30 days (n = 19) (p = 0.0022, Fig 1). Using serum 25(OH) D concentrations as a linear predictor of survival within the logistic regression model, none of the variables, including 25(OH)D concentration, were significant predictors of mortality. Since several studies in humans have also shown a non-linear relationship between vitamin D status and mortality [11, 40, 41], we investigated whether serum 25(OH)D concentrations were a significant predictor of mortality when represented as a categorical variable. We found that cats with a 25(OH)D concentration in the lower tertile had an increased risk of mortality compared to cats in the middle tertile reference category (Table 1). There was no significant difference in survival between cats in the upper and middle tertile (Table 1). The only other parameters which were associated with an increased risk of mortality by 30 days were potassium concentration and a reduced appetite (Table 1).
Box extends from 25th-75th percentiles with solid line representing the median value. Whiskers extend to 5th-95th percentiles.
Based on the results of the three tertile model and the epidemiological data which links low vitamin D status to poor health outcomes , we combined the middle and upper tertile into a single binary predictor in a third model. A serum 25(OH)D concentration in the lower tertile remained predictive of 30 day mortality (Table 2). Again, we found that potassium concentration and a reduced appetite were the only other parameters included in the third model which were predictive of survival (Table 2).
The central finding of this study demonstrates that hospitalised ill cats with low serum 25(OH)D concentrations were less likely to survive 30 days. Using a regression model which included serum 25(OH)D concentrations as a linear variable, none of the 12 clinical, biochemical and hematological parameters, including 25(OH)D concentrations, were predictive of mortality. However, when we performed a second analysis in which we included serum 25(OH)D concentrations as a categorical variable, we found that low vitamin D status was an independent predictor of short term mortality.
The finding that there was a relationship between low serum 25(OH)D concentrations and mortality is consistent with numerous human studies [13, 42, 43]. In addition, the observation that there was not a linear relationship between vitamin D status and survival is also consistent with studies in human patients [11, 40]. Several human studies have reported that there is minimal benefit of having high serum 25(OH)D concentrations and a number have linked high vitamin D status to negative health outcomes [40, 44].
There are a wide range of potential mechanisms by which low vitamin D status may influence health outcomes. The vitamin D receptor is expressed on many immune cell types and it is clear that vitamin D can modulate both the innate and acquired immune responses via effects on monocytes, macrophages, dendritic cells and lymphocytes [45, 46]. Vitamin D has also been shown to profoundly modulate pro-inflammatory responses [47, 48]. The pleiotropic extra-skeletal effects of vitamin D also extends to vascular function  and cellular proliferation and differentiation . Supplementation with vitamin D has also been shown to reduce pro-inflammatory cytokines in patients with cardiovascular disease . The renin-angiotensin system is also negatively regulated by vitamin D [52, 53]. Up-regulated renin-angiotensin activity is associated with systemic hypertension, renal dysfunction, vascular damage  and cardiac hypertrophy . Vitamin D is also inversely associated with parathyroid hormone, although this change is not seen in all patients with hypovitaminosis D , and excess parathyroid hormone has been related to increased risk of heart failure . All of these diverse effects of low vitamin D concentrations may impact on survival in domesticated cats.
Our study also demonstrated that reduced appetite was an independent predictor of short term mortality in cats. This finding is similar to human studies where reduced appetite has been linked to poor health outcomes in elderly patients . However, serum 25(OH)D concentrations remained a significant predictor of mortality when the results were corrected for reduced appetite. This suggests that the association between low serum vitamin D concentrations and mortality is not simply due to reduced dietary intake of vitamin D in hospitalised cats.
The study also demonstrated that potassium concentrations were linked to mortality with increasing potassium concentrations associated with poor survival outcomes. High serum potassium concentrations have been associated with mortality in critical care patients, even when increases in potassium are modest , and in patients with cardiac and renal disease . The mechanism(s) by which hyperkalemia influences mortality are unclear. However raised potassium concentrations can result in altered neurological, cardiac and muscular function . Furthermore, declining renal function is also associated with hyperkalemia  and hyperkalemia has been shown to be associated with serious infections and haemorrhage  which may in part explain its association with mortality.
In contrast to human medicine, little is known about the factors which are involved in all-cause mortality in cats. Previous studies have focused particularly on cats admitted to an intensive care unit (ICU), rather than across a wider hospital population [62, 63]. Therefore, the use of vitamin D to predict survival in a general hospital population is an important feature of this study. A previous reported predictor of feline survival is the Feline Acute Patient Physiologic and Laboratory Evaluation (Feline APPLE) Score . This scoring system has been validated only for feline ICU patients and requires several clinical and diagnostic parameters to be assessed. A univariable measure such as serum 25(OH)D concentration may provide a simpler and more readily usable predictor of mortality.
It cannot be concluded that serum 25(OH)D is causally linked to mortality from our finding that low vitamin D status is an independent risk factor of 30 day mortality in hospitalized, ill cats. This would require further prospective studies, including randomized, placebo controlled supplementation studies of cats with low vitamin D status. In light of our finding that cats with 25(OH)D concentrations in the upper tertile had a similar incidence of mortality as cats in the middle tertile, future studies should focus on assessing whether correction of hypovitaminosis D improves health outcomes. This approach is supported by observations from human trials in critically ill patients . Similarly, a study investigating the effects of vitamin D on cardiovascular morbidity and mortality, revealed that although supplementation improved overall survival, the effects were only significant in vitamin D deficient patients .
In conclusion, this study supports the hypothesis that low serum vitamin D status is predictive of 30 day mortality in hospitalised cats. The finding that low serum 25(OH)D concentrations are negatively correlated with survival supports the initiation of follow up clinical trials to examine the influence of vitamin D supplementation on disease outcome. Our study also indicates that domesticated cats with spontaneous illnesses may provide a valuable alternative to rodent models in which the effects of vitamin D on health outcomes can be probed without the need to induce disease in otherwise healthy animals.
The authors wish to thank all of the veterinarians and owners involved in the care of the cats in the study.
Conceived and designed the experiments: RM IH. Performed the experiments: SK DGM NR NB JS SK EB AB DG HT RM IH JB SL. Analyzed the data: IH HT RM. Contributed reagents/materials/analysis tools: HT RM IH JB. Wrote the paper: SK DGM NR NB JS SK EB AB DG HT RM IH JB SL.
- 1. The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement. Endocrine Reviews. 2012;33(3):456–92. pmid:22596255.
- 2. Christakos S, Dhawan P, Liu Y, Peng X, Porta A. New insights into the mechanisms of vitamin D action. Journal of cellular biochemistry. 2003;88(4):695–705. pmid:12577303
- 3. Tamez H, Thadhani RI. Vitamin D and hypertension: an update and review. Current opinion in nephrology and hypertension. 2012;21(5):492–9. pmid:22820371
- 4. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia. 2005;48(7):1247–57. pmid:15971062
- 5. Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Preventive medicine. 2010;51(3):228–33.
- 6. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. American Journal of Public Health. 2006;96(2):252. pmid:16380576
Kriegel MA, Manson JE, Costenbader KH, editors. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Seminars in arthritis and rheumatism; 2011: Elsevier.
- 8. Mehta S, Giovannucci E, Mugusi FM, Spiegelman D, Aboud S, Hertzmark E, et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One. 2010;5(1):e8770. pmid:20098738
- 9. Berry DJ, Hesketh K, Power C, Hyppönen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. British Journal of Nutrition. 2011;106(09):1433–40.
- 10. Quraishi SA, Litonjua AA, Moromizato T, Gibbons FK, Camargo CA, Giovannucci E, et al. Association between prehospital vitamin D status and hospital-acquired bloodstream infections. The American journal of clinical nutrition. 2013;98(4):952–9. pmid:23945717
- 11. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629–37. Epub 2008/08/13. pmid:18695076; PubMed Central PMCID: PMCPmc2677029.
- 12. Schottker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot L, et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ (Clinical research ed). 2014;348:g3656. Epub 2014/06/19. pmid:24938302; PubMed Central PMCID: PMCPmc4061380.
- 13. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012;95(1):91–100. Epub 2011/12/16. pmid:22170374.
- 14. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ (Clinical research ed). 2014;348:g1903. Epub 2014/04/03. pmid:24690623; PubMed Central PMCID: PMCPmc3972416.
- 15. Schottker B, Ball D, Gellert C, Brenner H. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing research reviews. 2013;12(2):708–18. Epub 2012/02/22. pmid:22343489.
- 16. Johnson MA, Davey A, Park S, Hausman DB, Poon LW. Age, race and season predict vitamin D status in African American and white octogenarians and centenarians. J Nutr Health Aging. 2008;12(10):690–5. pmid:19043643
- 17. Signorello LB, Williams SM, Zheng W, Smith JR, Long J, Cai Q, et al. Blood Vitamin D Levels in Relation to Genetic Estimation of African Ancestry. Cancer Epidemiology Biomarkers & Prevention. 2010;19(9):2325–31.
- 18. Weng FL, Shults J, Leonard MB, Stallings VA, Zemel BS. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. The American Journal of Clinical Nutrition. 2007;86(1):150–8. pmid:17616775
- 19. McAlindon TE, Felson DT, Zhang Y, Hannan MT, Aliabadi P, Weissman B, et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Annals of internal medicine. 1996;125(5):353–9. pmid:8702085
- 20. Brot C, Vestergaard P, Kolthoff N, Gram J, Hermann AP, Sørensen OH. Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. British Journal of Nutrition. 2001;86(S1):S97–S103.
- 21. Juttmann J, Visser T, Buurman C, De Kam E, Birkenhäger J. Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. British medical journal (Clinical research ed). 1981;282(6273):1349. pmid:6786491
- 22. Chapuy M-C, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International. 1997;7(5):439–43. pmid:9425501
- 23. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. Journal of Internal Medicine. 2000;247(2):260–8. pmid:10692090
- 24. Alagöl F, Shihadeh Y, Boztepe H, Tanakol R, Yarman S, Azizlerli H, et al. Sunlight exposure and vitamin D deficiency in Turkish women. Journal of Endocrinological Investigation. 2000;23(3):173–7. pmid:10803475
- 25. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. The American journal of clinical nutrition. 2000;72(3):690–3. pmid:10966885
- 26. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1, 25-dihydroxy vitamin D concentrations in healthy adults. The Journal of Clinical Endocrinology & Metabolism. 2004;89(3):1196–9.
- 27. Need AG, Morris HA, Horowitz M, Nordin C. Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D. The American Journal of Clinical Nutrition. 1993;58(6):882–5. pmid:8249872
- 28. Carnevale V, Modoni S, Pileri M, Di Giorgio A, Chiodini I, Minisola S, et al. Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporosis International. 2001;12(12):1026–30. pmid:11846328
Federation FEPFI. Nutritional Guidelines For Complete and Complementary Pet Food for Cats and Dogs. In: Federation FEPFI, editor. www.fediaf.org2014.
- 30. How K, Hazewinkel H, Mol J. Dietary vitamin D dependence of cat and dog due to inadequate cutaneous synthesis of vitamin D. General and comparative endocrinology. 1994;96(1):12–8. pmid:7843559
- 31. Morris JG. Ineffective vitamin D synthesis in cats is reversed by an inhibitor of 7-dehydrocholestrol-Δ7-reductase. The Journal of nutrition. 1999;129(4):903–8. pmid:10203568
- 32. Gow AG, Else R, Evans H, Berry JL, Herrtage ME, Mellanby RJ. Hypovitaminosis D in dogs with inflammatory bowel disease and hypoalbuminaemia. Journal of Small Animal Practice. 2011;52(8):411–8. pmid:21797872
- 33. Lalor S, Schwartz AM, Titmarsh H, Reed N, Tasker S, Boland L, et al. Cats with Inflammatory Bowel Disease and Intestinal Small Cell Lymphoma Have Low Serum Concentrations of 25-Hydroxyvitamin D. Journal of Veterinary Internal Medicine. 2014;28(2):351–5. pmid:24433362
- 34. Lalor SM, Mellanby RJ, Friend EJ, Bowlt KL, Berry J, Gunn-Moore D. Domesticated Cats with Active Mycobacteria Infections have Low Serum Vitamin D (25(OH)D) Concentrations. Transboundary and Emerging Diseases. 2012;59(3):279–81. pmid:21999899
- 35. Kovalik M, Thoday KL, Berry J, van den Broek AHM, Mellanby RJ. Prednisolone therapy for atopic dermatitis is less effective in dogs with lower pretreatment serum 25-hydroxyvitamin D concentrations. Veterinary Dermatology. 2012;23(2):125–e28. pmid:22141403
- 36. Mellanby RJ, Mellor P, Villiers EJ, Herrtage ME, Halsall D, O'Rahilly S, et al. Hypercalcaemia associated with granulomatous lymphadenitis and elevated 1,25 dihydroxyvitamin D concentration in a dog. The Journal of small animal practice. 2006;47(4):207–12. Epub 2006/04/01. pmid:16573764.
- 37. Rosa CT, Schoeman JP, Berry JL, Mellanby RJ, Dvir E. Hypovitaminosis D in dogs with spirocercosis. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 2013;27(5):1159–64. Epub 2013/08/21. pmid:23952621.
- 38. Mellanby RJ, Mellor PJ, Roulois A, Baines EA, Mee AP, Berry JL, et al. Hypocalcaemia associated with low serum vitamin D metabolite concentrations in two dogs with protein-losing enteropathies. The Journal of small animal practice. 2005;46(7):345–51. Epub 2005/07/23. pmid:16035452.
- 39. Wielders JPM, Wijnberg FA. Preanalytical Stability of 25(OH)—Vitamin D3 in Human Blood or Serum at Room Temperature: Solid as a Rock. Clinical Chemistry. 2009;55(8):1584–5. pmid:19541868
- 40. Durup D, Jorgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. The Journal of clinical endocrinology and metabolism. 2012;97(8):2644–52. Epub 2012/05/11. pmid:22573406.
- 41. Granic A, Aspray T, Hill T, Davies K, Collerton J, Martin-Ruiz C, et al. 25-hydroxyvitamin D and increased all-cause mortality in very old women: the Newcastle 85+ study. Journal of Internal Medicine. 2014:n/a-n/a.
- 42. Ginde AA, Scragg R, Schwartz RS, Camargo CA. Prospective Study of Serum 25-Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All-Cause Mortality in Older U.S. Adults. Journal of the American Geriatrics Society. 2009;57(9):1595–603. pmid:19549021
- 43. Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. European Journal of Endocrinology. 2010;162(5):935–42. pmid:20185562
- 44. Amrein K, Quraishi SA, Litonjua AA, Gibbons FK, Pieber TR, Camargo CA Jr., et al. Evidence for a U-shaped relationship between prehospital vitamin D status and mortality: a cohort study. The Journal of clinical endocrinology and metabolism. 2014;99(4):1461–9. Epub 2014/01/16. pmid:24423347; PubMed Central PMCID: PMCPmc3973775.
- 45. Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5(7):2502–21. Epub 2013/07/17. pmid:23857223; PubMed Central PMCID: PMCPmc3738984.
- 46. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Molecular Nutrition & Food Research. 2011;55(1):96–108.
- 47. Wobke TK, Sorg BL, Steinhilber D. Vitamin D in inflammatory diseases. Frontiers in physiology. 2014;5:244. Epub 2014/07/30. pmid:25071589; PubMed Central PMCID: PMCPmc4078458.
- 48. Yin K, Agrawal DK. Vitamin D and inflammatory diseases. Journal of inflammation research. 2014;7:69–87. Epub 2014/06/28. pmid:24971027; PubMed Central PMCID: PMCPmc4070857.
- 49. Ni W, Watts SW, Ng M, Chen S, Glenn DJ, Gardner DG. Elimination of Vitamin D Receptor in Vascular Endothelial Cells Alters Vascular Function. Hypertension. 2014.
- 50. Jensen SS, Madsen MW, Lukas J, Binderup L, Bartek J. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Molecular endocrinology (Baltimore, Md). 2001;15(8):1370–80. Epub 2001/07/21. pmid:11463860.
- 51. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. The American journal of clinical nutrition. 2006;83(4):754–9. pmid:16600924
- 52. Forman JP, Williams JS, Fisher NDL. Plasma 25-Hydroxyvitamin D and Regulation of the Renin-Angiotensin System in Humans. Hypertension. 2010;55(5):1283–8. pmid:20351344
- 53. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin—angiotensin system and blood pressure. The Journal of steroid biochemistry and molecular biology. 2004;89:387–92. pmid:15225806
- 54. van den Born B-JH, Koopmans RP, van Montfrans GA. The Renin-Angiotensin System in Malignant Hypertension Revisited: Plasma Renin Activity, Microangiopathic Hemolysis, and Renal Failure in Malignant Hypertension. American Journal of Hypertension. 2007;20(8):900–6. pmid:17679041
- 55. Yamazaki T, Komuro I, Shiojima I, Yazaki Y. The renin-angiotensin system and cardiac hypertrophy. Heart. 1996;76(3 Suppl 3):33–5. PMC484486. pmid:8977363
- 56. Shibli-Rahhal A, Paturi B. Variations in parathyroid hormone concentration in patients with low 25 hydroxyvitamin D. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014;25(7):1931–6. Epub 2014/03/22. pmid:24647889.
- 57. Bansal N, Zelnick L, Robinson-Cohen C, Hoofnagle AN, Ix JH, Lima JA, et al. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the multi-ethnic study of atherosclerosis. Journal of the American Heart Association. 2014;3(6):e001278. Epub 2014/12/04. pmid:25468653.
- 58. Huang YC, Wahlqvist ML, Lee MS. Appetite predicts mortality in free-living older adults in association with dietary diversity. A NAHSIT cohort study. Appetite. 2014;83:89–96. Epub 2014/08/19. pmid:25131903.
- 59. McMahon GM, Mendu ML, Gibbons FK, Christopher KB. Association between hyperkalemia at critical care initiation and mortality. Intensive care medicine. 2012;38(11):1834–42. Epub 2012/07/19. pmid:22806439.
- 60. Jain N, Kotla S, Little BB, Weideman RA, Brilakis ES, Reilly RF, et al. Predictors of hyperkalemia and death in patients with cardiac and renal disease. The American journal of cardiology. 2012;109(10):1510–3. Epub 2012/02/22. pmid:22342847.
- 61. Stevens MS, Dunlay RW. Hyperkalemia in hospitalized patients. International urology and nephrology. 2000;32(2):177–80. Epub 2001/03/07. pmid:11229629.
- 62. Simpson KE, McCann TM, Bommer NX, Pereira YM, Corston C, Reed N, et al. Retrospective analysis of selected predictors of mortality within a veterinary intensive care unit. Journal of feline medicine and surgery. 2007;9(5):364–8. pmid:17475528
- 63. Hayes G, Mathews K, Doig G, Kruth S, Boston S, Nykamp S, et al. The Feline Acute Patient Physiologic and Laboratory Evaluation (Feline APPLE) Score: A Severity of Illness Stratification System for Hospitalized Cats. Journal of Veterinary Internal Medicine. 2011;25(1):26–38. pmid:21143303
- 64. Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. Jama. 2014;312(15):1520–30. Epub 2014/10/01. pmid:25268295.
- 65. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D Deficiency and Supplementation and Relation to Cardiovascular Health. The American journal of cardiology. 2012;109(3):359–63. pmid:22071212